Thromboembolic events in children and young adults with pediatric sarcoma

Ido Paz-Priel, Lauren Long, Lee J. Helman, Crystal L. Mackall, Alan S. Wayne

Research output: Contribution to journalArticle

Abstract

Purpose: Adults with malignancy are at increased risk for venous thromboembolic events (TEs). However, data in children and young adults with cancer are limited. Patients and Methods: To determine the risk and clinical features of TEs in children and young adults with sarcoma, we reviewed records on 122 consecutive patients with sarcoma treated from October 1980 to July 2002. Results: Twenty-three TEs were diagnosed in 19 of 122 (16%; 95% CI, 10% to 23%) patients. Prevalence by diagnosis was Ewing sarcoma, eight of 61 (13%); osteosarcoma, two of 20 (10%); rhabdomyosarcoma, four of 26 (15%); and other sarcomas, five of 15 (33%). TEs developed in 23% of patients with metastases at presentation versus 10% with localized disease (odds ratio, 2.59; 95% CI, 0.9 to 7.1; P <.06). Fifty-three percent of patients with thrombosis had a clot at presentation. A lupus anticoagulant was detected in four of five evaluated patients. There was a single fatality due to pulmonary embolism. Patients who were diagnosed with cancer after 1993 had a higher rate of TE (7% v 23%; P <.015). Of the 23 events, 43% were asymptomatic. Main sites of thromboses were deep veins of the extremities (10 of 23; 43%), pulmonary embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%). TEs were associated with tumor compression in eight of 23 (35%) and with venous catheters in three of 23 (13%). Conclusion: Thromboembolism is common in pediatric patients with sarcomas. Thromboses are detected frequently around the time of oncologic presentation, may be asymptomatic, and seem to be associated with a higher disease burden. Children and young adults with sarcoma should be monitored closely for thrombosis.

Original languageEnglish (US)
Pages (from-to)1519-1524
Number of pages6
JournalJournal of Clinical Oncology
Volume25
Issue number12
DOIs
StatePublished - Apr 20 2007

Fingerprint

Sarcoma
Young Adult
Pediatrics
Thrombosis
Pulmonary Embolism
Neoplasms
Lupus Coagulation Inhibitor
Ewing's Sarcoma
Rhabdomyosarcoma
Thromboembolism
Inferior Vena Cava
Osteosarcoma
Venous Thrombosis
Catheters
Extremities
Odds Ratio
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Paz-Priel, I., Long, L., Helman, L. J., Mackall, C. L., & Wayne, A. S. (2007). Thromboembolic events in children and young adults with pediatric sarcoma. Journal of Clinical Oncology, 25(12), 1519-1524. https://doi.org/10.1200/JCO.2006.06.9930

Thromboembolic events in children and young adults with pediatric sarcoma. / Paz-Priel, Ido; Long, Lauren; Helman, Lee J.; Mackall, Crystal L.; Wayne, Alan S.

In: Journal of Clinical Oncology, Vol. 25, No. 12, 20.04.2007, p. 1519-1524.

Research output: Contribution to journalArticle

Paz-Priel, I, Long, L, Helman, LJ, Mackall, CL & Wayne, AS 2007, 'Thromboembolic events in children and young adults with pediatric sarcoma', Journal of Clinical Oncology, vol. 25, no. 12, pp. 1519-1524. https://doi.org/10.1200/JCO.2006.06.9930
Paz-Priel, Ido ; Long, Lauren ; Helman, Lee J. ; Mackall, Crystal L. ; Wayne, Alan S. / Thromboembolic events in children and young adults with pediatric sarcoma. In: Journal of Clinical Oncology. 2007 ; Vol. 25, No. 12. pp. 1519-1524.
@article{d9a1311d0f704b5c9729d582677f3174,
title = "Thromboembolic events in children and young adults with pediatric sarcoma",
abstract = "Purpose: Adults with malignancy are at increased risk for venous thromboembolic events (TEs). However, data in children and young adults with cancer are limited. Patients and Methods: To determine the risk and clinical features of TEs in children and young adults with sarcoma, we reviewed records on 122 consecutive patients with sarcoma treated from October 1980 to July 2002. Results: Twenty-three TEs were diagnosed in 19 of 122 (16{\%}; 95{\%} CI, 10{\%} to 23{\%}) patients. Prevalence by diagnosis was Ewing sarcoma, eight of 61 (13{\%}); osteosarcoma, two of 20 (10{\%}); rhabdomyosarcoma, four of 26 (15{\%}); and other sarcomas, five of 15 (33{\%}). TEs developed in 23{\%} of patients with metastases at presentation versus 10{\%} with localized disease (odds ratio, 2.59; 95{\%} CI, 0.9 to 7.1; P <.06). Fifty-three percent of patients with thrombosis had a clot at presentation. A lupus anticoagulant was detected in four of five evaluated patients. There was a single fatality due to pulmonary embolism. Patients who were diagnosed with cancer after 1993 had a higher rate of TE (7{\%} v 23{\%}; P <.015). Of the 23 events, 43{\%} were asymptomatic. Main sites of thromboses were deep veins of the extremities (10 of 23; 43{\%}), pulmonary embolism (five of 23; 22{\%}), and the inferior vena cava (four of 23; 17{\%}). TEs were associated with tumor compression in eight of 23 (35{\%}) and with venous catheters in three of 23 (13{\%}). Conclusion: Thromboembolism is common in pediatric patients with sarcomas. Thromboses are detected frequently around the time of oncologic presentation, may be asymptomatic, and seem to be associated with a higher disease burden. Children and young adults with sarcoma should be monitored closely for thrombosis.",
author = "Ido Paz-Priel and Lauren Long and Helman, {Lee J.} and Mackall, {Crystal L.} and Wayne, {Alan S.}",
year = "2007",
month = "4",
day = "20",
doi = "10.1200/JCO.2006.06.9930",
language = "English (US)",
volume = "25",
pages = "1519--1524",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "12",

}

TY - JOUR

T1 - Thromboembolic events in children and young adults with pediatric sarcoma

AU - Paz-Priel, Ido

AU - Long, Lauren

AU - Helman, Lee J.

AU - Mackall, Crystal L.

AU - Wayne, Alan S.

PY - 2007/4/20

Y1 - 2007/4/20

N2 - Purpose: Adults with malignancy are at increased risk for venous thromboembolic events (TEs). However, data in children and young adults with cancer are limited. Patients and Methods: To determine the risk and clinical features of TEs in children and young adults with sarcoma, we reviewed records on 122 consecutive patients with sarcoma treated from October 1980 to July 2002. Results: Twenty-three TEs were diagnosed in 19 of 122 (16%; 95% CI, 10% to 23%) patients. Prevalence by diagnosis was Ewing sarcoma, eight of 61 (13%); osteosarcoma, two of 20 (10%); rhabdomyosarcoma, four of 26 (15%); and other sarcomas, five of 15 (33%). TEs developed in 23% of patients with metastases at presentation versus 10% with localized disease (odds ratio, 2.59; 95% CI, 0.9 to 7.1; P <.06). Fifty-three percent of patients with thrombosis had a clot at presentation. A lupus anticoagulant was detected in four of five evaluated patients. There was a single fatality due to pulmonary embolism. Patients who were diagnosed with cancer after 1993 had a higher rate of TE (7% v 23%; P <.015). Of the 23 events, 43% were asymptomatic. Main sites of thromboses were deep veins of the extremities (10 of 23; 43%), pulmonary embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%). TEs were associated with tumor compression in eight of 23 (35%) and with venous catheters in three of 23 (13%). Conclusion: Thromboembolism is common in pediatric patients with sarcomas. Thromboses are detected frequently around the time of oncologic presentation, may be asymptomatic, and seem to be associated with a higher disease burden. Children and young adults with sarcoma should be monitored closely for thrombosis.

AB - Purpose: Adults with malignancy are at increased risk for venous thromboembolic events (TEs). However, data in children and young adults with cancer are limited. Patients and Methods: To determine the risk and clinical features of TEs in children and young adults with sarcoma, we reviewed records on 122 consecutive patients with sarcoma treated from October 1980 to July 2002. Results: Twenty-three TEs were diagnosed in 19 of 122 (16%; 95% CI, 10% to 23%) patients. Prevalence by diagnosis was Ewing sarcoma, eight of 61 (13%); osteosarcoma, two of 20 (10%); rhabdomyosarcoma, four of 26 (15%); and other sarcomas, five of 15 (33%). TEs developed in 23% of patients with metastases at presentation versus 10% with localized disease (odds ratio, 2.59; 95% CI, 0.9 to 7.1; P <.06). Fifty-three percent of patients with thrombosis had a clot at presentation. A lupus anticoagulant was detected in four of five evaluated patients. There was a single fatality due to pulmonary embolism. Patients who were diagnosed with cancer after 1993 had a higher rate of TE (7% v 23%; P <.015). Of the 23 events, 43% were asymptomatic. Main sites of thromboses were deep veins of the extremities (10 of 23; 43%), pulmonary embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%). TEs were associated with tumor compression in eight of 23 (35%) and with venous catheters in three of 23 (13%). Conclusion: Thromboembolism is common in pediatric patients with sarcomas. Thromboses are detected frequently around the time of oncologic presentation, may be asymptomatic, and seem to be associated with a higher disease burden. Children and young adults with sarcoma should be monitored closely for thrombosis.

UR - http://www.scopus.com/inward/record.url?scp=34248197473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248197473&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.06.9930

DO - 10.1200/JCO.2006.06.9930

M3 - Article

C2 - 17442994

AN - SCOPUS:34248197473

VL - 25

SP - 1519

EP - 1524

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 12

ER -